A Review of FLT3 Kinase Inhibitors in AML

Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the accumulation of abnormal hematopoietic precursors in both the bone marrow and peripheral blood. The prevalence of FLT3 gene mutations is high and escalates the probability of relapse and mortality. The survival rates fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Negotei, Cristina, Colita, Andrei, Mitu, Iuliana, Lupu, Anca Roxana, Lapadat, Mihai-Emilian, Popovici, Constanta Elena, Crainicu, Madalina, Stanca, Oana, Berbec, Nicoleta Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607239/
https://www.ncbi.nlm.nih.gov/pubmed/37892567
http://dx.doi.org/10.3390/jcm12206429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607239/
https://www.ncbi.nlm.nih.gov/pubmed/37892567
http://dx.doi.org/10.3390/jcm12206429

Ejemplares similares